Biotechs are driving most early stage programs, but facing limitations in the absorptive capacity of big pharma to take innovations to market
Refueling Innovation Engine Vaccines · page 18 of 40
The slide highlights the shift in R&D activity towards smaller players and emerging markets.
Consulting deck · industry_trends · analyze_data · dense density
Slide locked Sign in to view
Slide schematic 7/7
chart 3/3 disclaimer 1/1 source-note 1/1 title 2/2
Components 7
bar-vertical bar-vertical bar-vertical disclaimer source-note headline subtitle
Tools 1
Metrics 1
Frameworks 0
∅
No frameworks
No framework match is anchored to this slide.